Literature DB >> 11589912

Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia.

A Wallin1, M Sjögren.   

Abstract

The cerebrospinal fluid (CSF) levels of two cytoskeleton proteins, tau and the light subunit of neurofilament protein (NFL), both considered to reflect cerebral white-matter components, were investigated in a group of patients with a subtype of vascular dementia called 'subcortical white-matter dementia' (SWD). The group consisted of 25 demented patients with frontosubcortical brain syndromes, white-matter changes on computed tomography or magnetic resonance imaging and vascular disease or pronounced vascular risk factors. CSF-NFL was increased, whereas CSF-tau was normal, suggesting a differential involvement of the cytoskeleton in this patient group. The albumin ratio and the apolipoproteinE4 (ApoE4) allele status were also investigated. The albumin ratio was increased, indicating damage to the vessel walls with breakdown of the blood-brain barrier. No relationship was found between ApoE4 alleles and CSF levels of tau or NFL in this patient group. Besides presenting original data, the disease status of SWD is also discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589912     DOI: 10.1016/s0047-6374(01)00306-2

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  10 in total

1.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

2.  Cerebrospinal fluid analysis should be considered in patients with cognitive problems.

Authors:  Henrik Zetterberg; Niklas Mattsson; Kaj Blennow
Journal:  Int J Alzheimers Dis       Date:  2010-07-14

Review 3.  Biomarkers for cognitive impairment and dementia in elderly people.

Authors:  Joshua A Sonnen; Kathleen S Montine; Joseph F Quinn; Jeffrey A Kaye; John C S Breitner; Thomas J Montine
Journal:  Lancet Neurol       Date:  2008-08       Impact factor: 44.182

4.  Plasma Neurofilament Light Chain as a Predictive Biomarker for Post-stroke Cognitive Impairment: A Prospective Cohort Study.

Authors:  Zhiqiang Wang; Rongyu Wang; Yuxia Li; Mao Li; Yaodan Zhang; Lianyan Jiang; Jin Fan; Qingsong Wang; Dongdong Yang
Journal:  Front Aging Neurosci       Date:  2021-02-19       Impact factor: 5.750

5.  Protein markers for the differential diagnosis of vascular dementia and Alzheimer's disease.

Authors:  A H Simonsen; N-O Hagnelius; G Waldemar; T K Nilsson; J McGuire
Journal:  Int J Proteomics       Date:  2012-06-04

6.  Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.

Authors:  Pedro Rosa-Neto; Ging-Yuek Hsiung; Mario Masellis
Journal:  Alzheimers Res Ther       Date:  2013-11-25       Impact factor: 6.982

Review 7.  Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.

Authors:  A Wallin; E Kapaki; M Boban; S Engelborghs; D M Hermann; B Huisa; M Jonsson; M G Kramberger; L Lossi; B Malojcic; S Mehrabian; A Merighi; E B Mukaetova-Ladinska; G P Paraskevas; B O Popescu; R Ravid; L Traykov; G Tsivgoulis; G Weinstein; A Korczyn; M Bjerke; G Rosenberg
Journal:  BMC Neurol       Date:  2017-05-23       Impact factor: 2.474

Review 8.  Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.

Authors:  Anders Wallin; Gustavo C Román; Margaret Esiri; Petronella Kettunen; Johan Svensson; George P Paraskevas; Elisabeth Kapaki
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 9.  Recent updates on subcortical ischemic vascular dementia.

Authors:  Jee Hoon Roh; Jae-Hong Lee
Journal:  J Stroke       Date:  2014-01-31       Impact factor: 6.967

Review 10.  Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.

Authors:  Anders Wallin; Arto Nordlund; Michael Jonsson; Kaj Blennow; Henrik Zetterberg; Annika Öhrfelt; Jacob Stålhammar; Marie Eckerström; Mårten Carlsson; Erik Olsson; Mattias Göthlin; Johan Svensson; Sindre Rolstad; Carl Eckerström; Maria Bjerke
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.